(9-351) Financial Outcomes of Switching from Dipeptidyl Peptidase-4 Inhibitors to Sodium-Glucose Cotransporter 2 Inhibitors While on Metformin in Patients with Type 2 Diabetes and Cardiovascular Disease
Wednesday, December 7, 2022
8:30 AM – 9:30 AM
Location: Bayside A, Level 1
Category: Descriptive Report Topic: Chronic/Managed Care
Co-Author(s): Olga Ivanova, Madison Frazier, Anita Skaria, Ibukun Adetula
Primary Author(s)
Linh P. Nguyen, PharmD
Managed Care Resident Centene Corporation, California
